108984-6
Nuclear pore protein gp210 Ab [Measurement] in Serum
Trial
Status Information
- Status
- TRIAL
Term Description
This term is intended to collate similar measurements for the LOINC SNOMED CT Collaboration in an ontological view. Additionally, it can be used to communicate a laboratory order, either alone or in combination with specimen or other information in the order. It may NOT be used to report back the measured patient value. https://lo.inc/ce2mb6
Part Descriptions
LP447904-6 {Measurement}
{Measurement} is a Property grouper part used to collate terms with comparable measurement-related properties. It encompasses the following LOINC Properties: ACnc, AFr, ARat, CAct, CCnc, CCnt, CRat, CSub, EntLen, LaCnc, LnCnc, Mass, MCnc, MCnt, MRat, MRto, MSCnc, MSRat, Naric, NCnc, NFr, Prctl, PrThr, Ratio, SatFr, SCnc, SCnt, SRat, SRto, Sub, ThreshNum, Titr, and TmMCn.
Source: Regenstrief LOINC
LP71756-8 Nuclear pore protein gp210
Nuclear pore glycoprotein-210 (gp210) is an essential trafficking regulator in the eukaryotic nuclear pore complex. Gp-210 anchors the pore complex to the nuclear membrane and protein tagging reveals its primarily located on the luminal side of double layer membrane at the pore. A single polypeptide motif of gp210 is responsible for sorting to nuclear membrane,and indicate the carboxyl tail of the protein is oriented toward the cytoplasmic side of the membrane.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
LP71757-6 Nuclear pore protein gp210 Ab
Anti-glycoprotein-210 antibodies (AGPA, anti-gp210, anti-nup210, anti-np210) are directed at gp210 and are found within primary biliary cirrhosis (PBC) patients in high frequency. AGPA recognize the cytoplasmic oriented carboxyl terminus (tail) of the protein. While AGPA is found as a prognostic marker in only a minority of PBC patients those that did had higher mortality and predicts a poor outcome. In addition patients that responded to ursodeoxycholic acid (UDCA) therapy and, therefore, had AGPA reductions failed to develop end-stage liver disease relative to untreated cohort with anti-gp210 Ab.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
LOINC Names Get Info
- Fully-Specified Name
- Nuclear pore protein gp210 Ab:
{Measurement}: -: Ser: -: - Long Common Name
- Nuclear pore protein gp210 Ab [Measurement] in Serum
- Short Name
- Nuclear pore prot gp210 Ab Msmt Ser
- Display Name
- Nuclear pore protein gp210 Ab (S) [Measurement]
- Consumer Name Alpha Get Info
- Nuclear pore protein gp210 antibody, Blood
Part Model Get Info
Basic Attributes
- Class
- LABORDERS.ONTOLOGY
- Type
- Laboratory
- First Released
- Version 2.81
- Last Updated
- Version 2.81 (ADD)
- Order vs. Observation
- Order
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Proteína gp20 de los poros nucleares Anticuerpos: |
| fr-FR | French (France) | Pore nucléaire proteine gp210 Ac: |
| it-IT | Italian (Italy) | Pori nucleari, proteina gp210 Ab: Synonyms: anticorpo Codici richieste di laboratorio LABORDERS.ONTOLOGY Misurazione Proteina gp210 dei pori nucleari Siero |
| pl-PL | Polish (Poland) | Białko porów jądrowych gp210 Ab: Synonyms: Przeciwciała do białka porów jądrowych gp210 |
| zh-CN | Chinese (China) | 核孔蛋白 gp210 抗体: Synonyms: {测量}; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://